| Literature DB >> 30376848 |
Lara J Cooke1, Diane Duncan2, Laura Rivera2, Shawn K Dowling3, Christopher Symonds4, Heather Armson5.
Abstract
BACKGROUND: Audit and feedback interventions may be strengthened using social interaction. The Calgary office of the Alberta Physician Learning Program (CPLP) developed a process for audit and group feedback for physicians. This paper extends previous work in which we developed a conceptual model of physician responses to audit and group feedback based on a qualitative analysis of six audit and group feedback sessions. The present study explored the mediating factors for successfully engaging physician groups in change planning through audit and group feedback.Entities:
Keywords: Audit and feedback; Comparative case study; Feedback; Framework; Implementation; Knowledge translation; Physician learning; Practice improvement; Professional development; Social learning theory
Mesh:
Year: 2018 PMID: 30376848 PMCID: PMC6208022 DOI: 10.1186/s13012-018-0829-3
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Fig. 1The CPLP process from clinical question to AGFS. Physician groups bring clinical questions of interest for review by the CPLP. The CPLP team reviews the questions for appropriateness for audit and feedback. Consideration is given to impact, reach, actionability, and accessibility of the data. CPLP collaborates with data custodians to make individualized AF reports for consenting doctors. The confidential reports include individual data with anonymous peer comparators and relevant best practice information. Consenting physicians then participate in a facilitated group feedback session with their peers, led by a CPLP and/or participant facilitator. As a group, the physician peers review each aggregate data point, along with their own performance reports and seek opportunities for practice improvement
Descriptions of training and roles of CPLP staff and the research team
| CPLP staff participants | Description |
|---|---|
| Project managers (2) | The two CPLP project managers were experienced in audit and feedback project development and had formal project management training. |
| CPLP facilitator (CS) | A physician with experience in education and clinical research, who worked at the CPLP for 3 years as the program medical director. |
| Research team members | |
| LC | An academic clinician educator with training in medical education research and experience in knowledge translation and audit and feedback, who oversaw the CPLP program at the time when these AGFS occurred. |
| CS | See above. CS was the medical director at the time the AGFS were completed. |
| DD | CPLP project and program manager during the time that these AGFS took place. |
| LR | Research associate in CPLP when the AGFS were conducted. Training in epidemiology, quantitative and qualitative methodologies. |
| SD | A physician with training in epidemiology and knowledge translation who became the program medical director after the AGFS were developed. |
| HA | An academic professor of family medicine with training in knowledge translation, medical education and qualitative methodologies with extensive research experience with physician learning and feedback. |
Description of data sources for the framework analysis and how they were used by the research team
| Data sources | Description of how data was collected/used |
|---|---|
| Sample anonymous AF reports for each project | The research team reviewed the AF reports and described the quality of data visualization for each case. Through familiarization with the data from the first study, the team captured participant responses to the reports which could support or refute the team observations about the reports. Observations were noted in the framework table (Exemplar graphs from AF reports are shown in Figs. |
| Process evaluation for case 1 | A formal process evaluation of case 1 was conducted by a senior CPLP team member at the termination of that project. This was a seven-page document outlining processes, procedures, stakeholders, and lessons learned for this project. This report was reviewed by the researchers (LC, DD) information from the report that provided information about influencing social interaction in case 1 was added to the case 1 description in the framework table. |
| Transcripts and qualitative analysis of AGFS | An inductive thematic analysis of the transcripts for the six AGFS was conducted in a prior study [ |
| Structured interviews of CPLP staff | A staff member who observed each AGFS was interviewed using a the framework table as a structured guide. They were asked to comment about each element in the framework for each case. Their responses were captured in notes entered directly into the framework analysis table. Likewise, the facilitator of the six sessions was interviewed and all responses were captured in the same document. |
| CPLP tracking document | Basic information about each AGFS was captured by the CPLP staff in a tracking document maintained by the program. These included key performance indicators such as numbers of reports distributed, timing of AGFS. |
| Observations of the research team | A consensus meeting of members of the research team (LC, HA, LR, DD) was held to share and compare observations of the AGFS and AGF projects. These observations were captured and noted directly into the framework table. This content was reviewed iteratively during the case analysis and during the development of the CAFF to ensure accuracy and consensus about the findings for each case that was analyzed. Observations of the research team were triangulated with the other data sources for corroboration. |
Program model for the comparative case analysis
| Program model elements | Components |
|---|---|
| Innovation [ | The clinical question upon which the project was based |
| Style of report [ | Design of the report, co-creation of report design with CPLP and physician leads from participating groups |
| Available gold standard/benchmark for the clinical question [ | |
| Recipients [ | Who participants were and how they interacted with one another [ |
| Context [ | Project origin/history |
| Facilitation [ | CPLP led or co-facilitated with a participant physician-lead |
| Physician engagement/change talk/change planning [ | Interactivity of the AGFS, extent of change talk |
| Outputs | Further project development with CPLP |
Representative examples of data that were used in building the case studies. In this table, the way in which raw data was indexed to the components of the program model is shown. Where relevant, how this data was linked to the key elements of the CAFF model is also shown in order to demonstrate the way in which inferences were drawn between the original raw data, the program model, and, ultimately, the framework
| CAFF model element (overarching theme) | Component of program model | Example findings from case analysis extracted from transcripts | Representative quotations |
|---|---|---|---|
| Facilitation: | Physician engagement/change talk/change planning [ | A high degree of social interaction in case 1. Data captured from original AGFS transcripts | Reflecting and sharing of practices around using intravenous anesthesia: |
| Facilitation: | Physician engagement/change talk/change planning [ | Case 2A | A participant expressed their desire to improve their prescribing habits: |
| Recipients and context | Case 2D: | “We are a relatively younger group compared to some... And I think a lot of us try to utilize… restraint in antipsychotic prescriptions. We have had good teams involved with a lot of our patients and we try and avoid a lot of that.” | |
| Data representation | Style of report | Case 2D: Participants raised concerns about the complexity and cognitive load in their AF reports. | “But when you first look at the document… it is very difficult to understand a lot of it, because there’s a lot of information.” |
| Examples of data extracted from interviews with CPLP Staff | Representative quotations | ||
| Relationship building and question choice | Recipients, innovation, and context | When asked about how the project originated and nature of the innovation (case 1): | CPLP facilitator: “Many of these docs had been involved in [our first] project, but there were some younger recent grads who were more involved in choosing questions—NAME was seen as a strong leader, group had bought into his vision of education in general and the idea of audit and feedback. Maybe the group generally has a culture of monitoring and data collection—… not a big sell to this group – they were keen, thoughtful, interested, and academic in their thinking….they had the advantage of having already been through the process. Lots of groundwork done by our team working with the clinic staff, daycare staff, data analyst, etc... lots of face time from PLP on site—seemed to be helpful with buy in.” |
| Relationship Building & Question Choice | Physician Engagement/Change Talk/Change Planning [ | When asked about group dynamic (case 2D): | Facilitator: “Poor participation from the group. The group culture at this hospital seemed different from the other groups…very silent during the session…not very many showed up..for their reports”. Project manager 1: “[The participants were] young. Did they feel uncomfortable speaking up?” |
| Question choice | Innovation | When asked about nature of the project case 3: | Project manager 2: “The goal was hazy…very broad—things that were common”. |
| Relationship building | Recipients and context | Describing the recipients (case 3): | Facilitator: “This group is super engaged. A bunch of XXX residents who may have been friends before, or became friends afterwards—they are all about the same age, early millenials mostly all on the same page. The group was on the same page. NAME is a competent, quiet leader … very practical, down to earth, that’s why NAME was asked to do this. The group is tight because they cover for one another and cross-cover. The mean age of this group was particularly young – sense of buy in to data, computers, digital natives. Had many suggestions …came up with at least ten potential projects. They were keen – lots of sharing of one another’s data in the sessions”. |
Summary of results of comparative case analysis for six audit and feedback sessions with different physician groups. The program model elements, which formed the framework table used for data analysis and indexing are on the vertical axis of this table and the cases are listed across the horizontal. The results presented below are summarized, for purposes of the publication, from the detailed notations captured in the original framework tables. The data sources from which the data were extracted are described in Table 1
| Program model elements | Case 1 | Case 2a | Case 2b | Case 2c | Case 2d | Case 3 | |
|---|---|---|---|---|---|---|---|
| Innovation | Review of practice variation and outcomes of anesthesia for procedure x | Review of prescribing practice variation for medications in population x at hospital A | Review of prescribing practice variation for medications in population x at hospital B | Review of prescribing practice variation for medications in population x at hospital C | Review of prescribing practice variation for medications in population x at hospital D | Survey of practice variation in anesthesia for 5 procedures at Hospital A. A survey/overview of practice type of project in preparation for a more subsequent specific project. Intent to introduce the group to A&F | |
| For this project, A&F was one component of a multifaceted intervention: It was preceded by a didactic inter-professional (doctors, nurses, pharmacists) continuing medical education session, and subsequently included a communication campaign and changes to physician order entry sets, which stemmed from this series of AGFS (cases 2A–D) | |||||||
| Style of audit report | Highly refined with heavy group input | The reports across cases 2A–D presented the same aggregate data, but had individual physician data for the participating physicians at each site. In each of these four AGFS, a significant amount of time was spent with the participants asking questions to try to understand the data as it was presented | Engaged group lead contributed substantially to report design | ||||
| One of the two project leads was from this site and helped to refine the question for the AF reports | One of the two project leads for this work came from this site and helped to co-create and refine the question for the AF reports | 2D Participants commented during the AGFS that the report was difficult to interpret during the AGFS | |||||
| Gold standard for proposed best practice | None | No, but several existing guidelines and recommendations | No, but existing evidence and guidelines. | ||||
| Recipients | Specialists at hospital 1. | Generalist physician group, nurse managers, QI lead at hospitals A, B, C, and D respectively (64 physician reports, 28 physicians attended feedback sessions) | Specialist group, hospital D | ||||
| Participants in this group identified that their patient population included hospice patients and felt that this influenced prescribing behaviors | Participants in this group cared for very high volume services with high degrees of acuity and complexity | Participants at this site identified that they care for an older patient population. This site had access to a geriatric psychiatry service which may have influenced prescribing patterns. They were positively oriented, cohesive, non-judgmental | Participants at this site self-identified as being “younger” and felt that their prescribing behaviors were influenced heavily by their training and by the local consultants with whom they collaborated | ||||
| Context | Project origin | A second project with CPLP for this group | A question raised by city-wide Innovation Committee who invited CPLP to develop the AF reports and deliver AGFS across the 4 sites | CPLP invited by this group after they learned about case 1 | |||
| Group dynamic and leadership involvement for the A&F sessions | Experienced, respected senior physician with strong commitment to professional development. | One project lead was a member of this group but was not able to attend this session. The site lead was present but did not have facilitator role in session. Nonetheless, CPLP staff identified that the site lead was “a strong lead” and contributed to the session meaningfully. Lots of questioning and discussion about why this site might be different vs others, skepticism regarding data, requests for data that were not included in original project. | Site lead present. Lots of questioning of data and discussion about how the data was analyzed. Site lead expressed concern re potential defensiveness of group prior to AGFS. Good attendance. | One of the two project leads was from this site. Some good discussion in session, but CPLP staff noted that participants began sharing and comparing data as the CPLP team left the room. Good attendance. Project lead shared own data. | Young physician group in a new hospital working in 2 week shifts with lots of handover. Poor attendance, few questions at session. | Very motivated, dynamic site project lead with an admin position for education within the group. A young physician cohort, digitally literate, open to self-reflection, keen to discuss change and understand findings. Group cohesion and collegiality high, in part because of call structure. | |
| Pre-work, relationship-building | This was a second project for this group. Lots of interaction with CPLP team in project development | This was a first project for each of the four hospital groups. There were several meetings with the two project leads (From cases 2A and 2C) and a meeting with the city-wide QI group (at site 2B), but not with group members | First contact was by invitation: CPLP presented to the entire physician group to introduce concept of A&F program. Project lead met frequently with MD group and CPLP team | ||||
| Co-creation of data/metrics | A working group with a strong lead and three department members and input from MD group developed metrics and report | This was one part of a larger project. Individual physicians at each site did not choose what question would be addressed; however, the question was brought to the CPLP by the two project leads (From sites 2A and 2C) and was aligned with a provincial initiative to de-prescribe in this population. The project leads helped the CPLP team to determine which data points to build into the reports | Strong leadership from site lead and collaborative development of project between site lead and MD group members | ||||
| Proximity of doctor to data and patient | Direct physicians administering orders at bedside | In-direct: Admitting physician was not always attending, many orders were PRN and at discretion of nursing staff. MDs did not feel they had good control over nurse discretion nor order entry system | Direct, as in case 1, and MDs had direct access to database designers for data capture/metrics | ||||
| Facilitation of Session | Co-led by CPLP and group champion who presented own data to group. Prompting and questions from CPLP and from co-facilitator | CPLP facilitator, who was a physician but not a group member, led each session. Facilitation followed structure of the report, table by table. For case 2C, exemplar data from the site lead’s report was presented but the session was still based on structure of the report. Some degree of input from site lead occurred at sites 2A, B, but not at site C or D. | Led by CPLP facilitator with substantive input from project lead. Prompting questions from both CPLP facilitator and project lead | ||||
| Engagement/change talk/action planning | Very interactive. Lots of sharing of personal practices and planning around additional change activities | Moderate interaction. Some change cues were raised, leading to plans for change, and some sharing of practices occurred | Moderate. A participant spontaneously raised need for change and this led to considerable discussion of how this could be achieved including engagement of nursing staff and making a collective commitment to de-prescribing | Minimal. There was little change discussion during this AGFS, but participants did share and compare practices to some extent | Minimal. The group asked questions related only to understanding the data. No change cues arose in this AGFS | Very dynamic session with lots of questions on evidence directed to the project lead and discussion between group members | |
| Other outputs | Led to 7 subsequent projects with same specialty in different settings with different innovations and to development of continuous reporting platform for all doctors in this specialty | This AGFS occurred after the education campaign that was a part of the larger initiative. There was no change in prescribing from baseline to this AGFS. However, 1 year after this AGFS, there was a relative reduction in prescribing over all four sites of 39% during study period. | Specific feedback in follow-up from one group member who changed opioid practice subsequently after learning about practice variation vs other members. Led to follow-up projects with same group looking at other clinical questions and ultimately additional projects in city-wide department (see case 1) | ||||
Fig. 2The Calgary Audit and Feedback Framework (CAFF) for the design and delivery of AGF. This model organizes the key findings from our case analysis that were identified as important drivers in moving physicians through the cycle of discrete behaviors that occur in AGFS towards the end goal of planning for change. Under each “mediating factor” are listed the distinguishing elements between the cases with more or less social interaction that emerged from the comparative case analysis. The framework is linked to the conceptual model of physician behaviors in AGFs to show how the different mediating factors drive the behaviors towards change
Fig. 3Representative example of a single data table from a generic report from the case 1 project. Physicians appeared to be readily able to interpret these graphs during the AGFS, allowing more time for reflection and planning for change
Fig. 4This graph is an aggregate exemplar of how the data for cases 2A–D were initially presented. The goal was to show physicians whether they were discontinuing sedatives and anti-psychotics in patients who were admitted with a pre-existing prescription, whether the patients were started on these medications in hospital, and whether they remained on them after discharge. A desirable outcome for a patient on sedatives or anti-psychotics either before or during their hospital stay was considered to be discharge from hospital without a prescription for these medications. Physicians found these graphs challenging to interpret, resulting in disproportionate AGFS time being spent on clarifying and questioning